Blood-brain barrier drug delivery problems of existing neuropharmaceuticals can be solved using genetically engineered molecular Trojan horses. A novel tailor-made Trojan horse drug that quickly switches into an aggressive molecule to destroy even the residual amyloid plaques could be more effective than any known drug thus far developed for Alzheimer’s disease.
Amal Aziz
Blood-brain barrier drug delivery problems of existing neuropharmaceuticals can be solved using genetically engineered molecular Trojan horses. A novel tailor-made Trojan horse drug that quickly switches into an aggressive molecule to destroy even the residual amyloid plaques could be more effective than any known drug thus far developed for Alzheimer’s disease.